SAVAYSA (Daiichi Sankyo, Inc.)


Welcome to the PulseAid listing for the SAVAYSA drug offered from Daiichi Sankyo, Inc.. This Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Daiichi Sankyo, Inc.
NON-PROPRIETARY NAME: EDOXABAN TOSYLATE
SUBSTANCE NAME: EDOXABAN TOSYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-01-12
END MARKETING DATE: 0000-00-00


SAVAYSA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSAVAYSA from Daiichi Sankyo, Inc.
LABELER NAME: Daiichi Sankyo, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 15(mg/1)
START MARKETING DATE: 2015-01-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65597-201_0b27d664-baa2-4208-ab84-2b8735daceec
PRODUCT NDC: 65597-201
APPLICATION NUMBER: NDA206316

Other EDOXABAN TOSYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Daiichi Sankyo, Inc.SAVAYSA